US2010222292A1PendingUtilityA1
Method for transdifferentiation of body tissues
Est. expiryJul 29, 2019(expired)· nominal 20-yr term from priority
Inventors:Steven Baranowitz
A61K 31/015A61P 35/00C07H 19/167A61K 31/708A61K 31/706A61P 43/00A61K 31/7076
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to methods for transdifferentiation of body tissues which can be used to generate specific cell types needed for regenerating organs or body parts, following cellular degeneration, injury or amputation. The present invention also describes the use of tissue transdifferentiation for treating cancer and autoimmune diseases.
Claims
exact text as granted — not AI-modified1 . A method for treating melanoma in a mammal comprising administering to a mammal in need of such treatment an amount of a guanosine-containing compound effective to treat melanoma.
2 . The method of claim 1 further comprising administering an amount of beta-carotene effective to treat melanoma.
3 . The method of claim 1 wherein said guanosine-containing compound is guanosine monophosphate.
4 . The method of claim 1 wherein said guanosine-containing compound is administered systemically.
5 . The method of claim 2 wherein said beta-carotene is administered systemically.
6 . A method for treating melanoma in a mammal comprising contacting said melanoma with an amount of guanosine monophosphate effective to treat melanoma.
7 . The method of claim 6 further comprising contacting said melanoma with an amount of beta-carotene effective to treat melanoma.
8 . A method for treating melanoma in a mammal comprising contacting said melanoma with an amount of adenosine effective to treat melanoma.
9 . The method of claim 8 further comprising contacting said melanoma with an amount of retinoic acid effective to treat melanoma.
10 . A method for treating melanoma in a mammal comprising administering to a mammal in need of such treatment an amount of adenosine effective to treat melanoma.
11 . The method of claim 10 further comprising administering an amount of retinoic acid effective to treat melanoma.Join the waitlist — get patent alerts
Track US2010222292A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.